Literature DB >> 9800289

Changes in red-cell transfusion practice in a tertiary care hospital during the 1990s--a 7-year study.

P H Pinkerton1, T Tasev, A S Coovadia.   

Abstract

Use of red cells for transfusion in a tertiary care hospital has been studied over a 7-year period from 1990-1991 to 1996-1997. In this time, red-cell use has declined by 18% while new patients or admissions to programmes in oncology, trauma or cardiac bypass surgery have increased by 57%, 66% and 73%, respectively. This reduction in red-cell transfusion has been achieved by a combination of less patients (proportionately) receiving red cells and less red cells being transfused to individual recipients. When the trends are analysed for red-cell use in four elective surgical procedures there is a significant reduction in both the proportion of patients transfused and the mean number of units used per patient undergoing the procedure. Autologous presurgical blood deposit met about 45% of the blood requirement for those four procedures. A similar decreasing trend in units per patient and proportion of patients transfused red cells was seen for 'first-time' coronary artery bypass surgery. The question arises as to how far this trend may go before adverse effects of undertransfusion become apparent.

Entities:  

Mesh:

Year:  1998        PMID: 9800289     DOI: 10.1046/j.1365-3148.1998.00158.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  2 in total

1.  Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Authors:  Jo Anne Chiavetta; Michael Escobar; Alice Newman; Yaohua He; Pete Driezen; Shelley Deeks; Devon E Hone; Sheila F O'Brien; Graham Sher
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

2.  Change in use of allogeneic red blood cell transfusions among surgical patients.

Authors:  Julius Cuong Pham; Christina L Catlett; Sean M Berenholtz; Elliott R Haut
Journal:  J Am Coll Surg       Date:  2008-06-02       Impact factor: 6.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.